INTERFERON PURCHASES EXCEED $5 MIL. ANNUALLY AT MD ANDERSON; GROWTH FACTOR SPENDING HAS HIT $1 MIL./MONTH: COSTS PROMPTING EFFORTS TO "OPTIMIZE" DOSING